Efficacy and Safety of 675-nm Laser for Dorsal Hand Rejuvenation
Launched by MAHIDOL UNIVERSITY · Jun 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a special 675-nm laser to improve the appearance of wrinkles on the backs of the hands. The researchers want to find out if this treatment is safe and effective for people aged 50 to 65 who have wrinkles and sunspots on their hands. In the trial, participants will receive the laser treatment three times over a period of 12 weeks and will be followed up for 3 and 6 months after their last treatment to assess the results.
To join the study, participants must have visible wrinkles and sunspots on their hands. However, some people cannot participate, such as those who are pregnant or breastfeeding, have allergies to certain light treatments, or have had other hand treatments recently. Throughout the trial, participants can expect to have their progress evaluated through simple assessments of their skin's appearance and texture. This study is not yet open for recruitment, but it aims to provide new insights into non-invasive ways to rejuvenate the skin on the hands.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects diagnosed with wrinkles and solar lentigines on both dorsum of hands
- Exclusion Criteria:
- • Pregnant or lactation
- • Sugjects with a history of allergy to near-infrared wavelength or photosensitizing agents
- • Subjects who have been treated with any kind of energy-based device on both dorsum of hands 6 months prior to the inclusion
- • Subjects who have been injected with filler, or platelet-rich plasma on both dorsum of hands on their faces 6 months prior to the inclusion
- • Active skin infections
- • History of hypertrophic scars or keloids
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Woraphong Manuskiatti, MD
Principal Investigator
Mahidol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported